AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site L208A
Virus Human respiratory syncytial virus
Mutation level Amino acid Level
Gene/protein/region type L
Gene ID 1494467
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence M74568.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase
Uniprot protein ID P28887
Protein length 2165 amino acids
Protein description The core polymerase in RSV is composed of two proteins, a 250 kDa polymerase subunit (L), which contains the RNA-dependent RNA polymerase, the polyribonucleotidyl transferase (PRNTase, capping), and the methyltransferase enzymatic domains essential for viral transcription and replication, and the 27 kDa phosphoprotein (P) accessory protein. . The L protein caps mRNA by a unique RNA-GDP polyribonucleotidyl transferase activity mapped to conserved region V (CRV). Methylation of the cap at the guanine-N-7 and ribose-2-O positions is catalyzed by a unique dual specificity methyltransferase activity that has been functionally mapped to region VI of the L protein.

Literature information:


Pubmed ID 33177201
Clinical information No
Disease -
Published year 2021
Journal Journal of virology
Title A Novel Live Attenuated Respiratory Syncytial Virus Vaccine Candidate with Mutations in the L Protein SAM Binding Site and the G Protein Cleavage Site Is Protective in Cotton Rats and a Rhesus Macaque
Author Tiffany Jenkins,Rongzhang Wang,Olivia Harder,Miaoge Xue,Phylip Chen
Evidence Here, we have combined these two mutations in one recombinant green fluorescent protein (GFP)-expressing virus, rgRSV-G(L208A)-L(G1857A), and compared its immunogenicity to viruses with each mutation alone and with the parental virus.